Acro Biomedical (ACBM) Cash from Financing Activities (2017 - 2025)
Acro Biomedical (ACBM) posted Cash from Financing Activities of $25152.0 for Q4 2025, down 57.16% on a QoQ basis from $58707.0 in Q3 2025, and up 144.43% year-over-year from $10290.0 in Q4 2024.
Powered by 
Analysis
Acro Biomedical (ACBM) Cash from Financing Activities (2017 - 2025) Analysis & Trends
Acro Biomedical has reported Cash from Financing Activities for 9 years, with the latest figure at $25152.0 in Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 144.43% year-over-year to $25152.0 in Q4 2025; TTM through Dec 2025 was $199924.0, a 443.39% increase from a year earlier, with the FY2025 full-year figure at $199924.0, up 443.39% from the prior year.
- Cash from Financing Activities was $25152.0 for Q4 2025 at Acro Biomedical, down from $58707.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $93759.0 in Q2 2025, with the low at -$241635.0 in Q2 2021.
- Average Cash from Financing Activities over 5 years is $4128.0, with a median of $6607.0 recorded in 2024.
- The sharpest annual moves came in 2021 and 2024: Cash from Financing Activities plunged 492.42% in 2021, then jumped 36811.11% in 2024.
- Over 5 years, Cash from Financing Activities stood at $1091.0 in 2021, then plunged by 78.74% to $232.0 in 2022, then surged by 4088.79% to $9718.0 in 2023, then rose by 5.89% to $10290.0 in 2024, then surged by 144.43% to $25152.0 in 2025.
- The last three Cash from Financing Activities figures came in at $25152.0 (Q4 2025), $58707.0 (Q3 2025), and $93759.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | -851.00 Mn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | -587.00 Mn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 305.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | -388.90 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -82.70 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | -7.30 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 25,152.00 |
| Sep 30, 2025 | 58,707.00 |
| Jun 30, 2025 | 93,759.00 |
| Mar 31, 2025 | 22,306.00 |
| Dec 31, 2024 | 10,290.00 |
| Sep 30, 2024 | 6,110.00 |
| Jun 30, 2024 | 7,104.00 |
| Mar 31, 2024 | 13,288.00 |
| Dec 31, 2023 | 9,718.00 |
| Sep 30, 2023 | 108.00 |
| Jun 30, 2023 | 108.00 |
| Mar 31, 2023 | 36.00 |
| Dec 31, 2022 | 232.00 |
| Sep 30, 2022 | 57,349.00 |
| Jun 30, 2022 | 216.00 |
| Mar 31, 2022 | 288.00 |
| Dec 31, 2021 | 1,091.00 |
| Sep 30, 2021 | 3,718.00 |
| Jun 30, 2021 | -241,635.00 |
| Mar 31, 2021 | 14,616.00 |